Q&A

Exclusive interviews with industry leaders


  • story image
    Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    Kim Ribbink • Jan. 10, 2022
  • story image
    Image attribution tooltip
    Justin Sullivan/ via Getty Images

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

    Meagan Parrish • Jan. 10, 2022
  • story image
    Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Last Word: PharmaVOICE The Next Frontier

    With Industry Dive acquiring PharmaVOICE, Taren Grom, Editor of PharmaVOICE, sat down with Davide Savenije, Editor-in-Chief of Industry Dive, to discuss what’s coming in 2022, and what you, our community, can expect with the relaunch in January. PV: After 20-plus years as a print publica...

    Davide Savenije • Nov. 15, 2021
  • story image
    Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Last Word

    Six Keys to Beating the Odds and Achieving Startup Success Sharon Cunningham, Co-founder and CEO of Shorla Pharma, details the six steps she and her partner undertook to launch a successful biopharma company. PV: What was it like starting up Shorla Pharma? Cunningham: Starting your own c...

    Sharon Cunningham • Nov. 16, 2020
  • story image
    Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Last Word

    The Impact Of COVID-19 On The Workplace Laurie Cooke, President and CEO of the Healthcare Businesswomen’s Association (HBA), highlights some of the ways the pandemic is impacting companies and employees across the industry. PV: The HBA conducted a survey among its corporate partner co...

    Laurie Cooke • Oct. 1, 2020
  • story image
    Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Last Word

    Transforming the Practice of Medicine John Cox, CEO of Repertoire Immune Medicines — a clinical-stage immuno-therapy company — talks about unleashing the curative powers of the immune system to prevent and cure cancer, autoimmune, and infectious diseases. PV: Repertoire Therapeu...

    John Cox • April 1, 2020